USP7-IN-13

USP7-IN-13

• CAS Number: 2305046-93-7
• UNSPSC Description: USP7-IN-13 (Compound 101) is a USP7 inhibitor with an IC50 value of 0.2-1 μM, which can be used for the study of multiple myeloma[1].
• Target Antigen: Deubiquitinase
• Type: Reference compound
• Related Pathways: Cell Cycle/DNA Damage
• Applications: Cancer-programmed cell death
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/usp7-in-13.html
• Solubility: DMSO : 200 mg/mL (ultrasonic)
• Smiles: O=C1C2=CC=C(N)C=C2N=CN1CC3(CCN(CC3)C(C[C@H](C4=CC=CC=C4)C)=O)O
• Molecular Weight: 420.50
• References & Citations: [1]Buhrlage, Sara, et al. "Novel usp7 inhibitors for treating multiple myeloma." U.S. Patent. WO2019067503. 2019-04-04
• Shipping Conditions: Room Temperature
• Clinical Information: No Development Reported